Jang A - Search Results

1

Targeted Alpha-Particle Therapy: A Review of Current Trials.

Jang A, Kendi AT, Johnson GB, Halfdanarson TR, Sartor O. Jang A, et al. Int J Mol Sci. 2023 Jul 19;24(14):11626. doi: 10.3390/ijms241411626. Int J Mol Sci. 2023. PMID: 37511386 Free PMC article. Review.

2

Therapeutic Potential of PARP Inhibitors in the Treatment of Metastatic Castration-Resistant Prostate Cancer.

Jang A, Sartor O, Barata PC, Paller CJ. Jang A, et al. Cancers (Basel). 2020 Nov 21;12(11):3467. doi: 10.3390/cancers12113467. Cancers (Basel). 2020. PMID: 33233320 Free PMC article. Review.

3

Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer.

Freeman MN, Jang A, Zhu J, Sanati F, Nandagopal L, Ravindranathan D, Desai A, Phone A, Nussenzveig R, Jaeger E, Caputo SA, Koshkin VS, Swami U, Basu A, Bilen MA, Agarwal N, Sartor O, Burgess EF, Barata PC. Freeman MN, et al. Among authors: jang a. Oncologist. 2022 Mar 11;27(3):220-227. doi: 10.1093/oncolo/oyab057. Oncologist. 2022. PMID: 35274720 Free PMC article.

4

Clinical and Genetic Analysis of Metastatic Prostate Cancer to the Central Nervous System: A Single-Institution Retrospective Experience.

Jang A, Jaeger EB, Ledet EM, Xie J, Lewis BE, Layton JL, Sartor O, Barata PC, Trevino CR. Jang A, et al. Clin Genitourin Cancer. 2023 Apr;21(2):e9-e18. doi: 10.1016/j.clgc.2022.10.007. Epub 2022 Oct 20. Clin Genitourin Cancer. 2023. PMID: 36376168

5

Status of PSMA-targeted radioligand therapy in prostate cancer: current data and future trials.

Jang A, Kendi AT, Sartor O. Jang A, et al. Ther Adv Med Oncol. 2023 Mar 4;15:17588359231157632. doi: 10.1177/17588359231157632. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 36895851 Free PMC article. Review.

6

Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate-resistant prostate cancer post-abiraterone and/or enzalutamide.

Jang A, Lanka SM, Huang M, Casado CV, Caputo SA, Sweeney PL, Gupta K, Pocha O, Habibian N, Hawkins ME, Lieberman AD, Schwartz J, Jaeger EB, Miller PJ, Layton JL, Barata PC, Lewis BE, Ledet EM, Sartor O. Jang A, et al. Prostate. 2023 Aug;83(11):1028-1034. doi: 10.1002/pros.24544. Epub 2023 Apr 27. Prostate. 2023. PMID: 37113064

7

Advanced papillary renal cell carcinoma: Epidemiology, genomic drivers, current therapies, and ongoing trials.

Sweeney PL, Jang A, Halat SK, Pal SK, Barata PC. Sweeney PL, et al. Among authors: jang a. Cancer Treat Res Commun. 2022;33:100639. doi: 10.1016/j.ctarc.2022.100639. Epub 2022 Sep 22. Cancer Treat Res Commun. 2022. PMID: 36162322 Free article.

8

Overcoming Obstacles in Liquid Biopsy Developments for Prostate Cancer.

Jang A, Rauterkus GP, Vaishampayan UN, Barata PC. Jang A, et al. Onco Targets Ther. 2022 Aug 26;15:897-912. doi: 10.2147/OTT.S285758. eCollection 2022. Onco Targets Ther. 2022. PMID: 36051571 Free PMC article. Review.

9

Novel therapies for metastatic prostate cancer.

Jang A, Lanka SM, Ruan HT, Kumar HLS, Jia AY, Garcia JA, Mian OY, Barata PC. Jang A, et al. Expert Rev Anticancer Ther. 2023 Jul-Dec;23(12):1251-1263. doi: 10.1080/14737140.2023.2290197. Epub 2023 Dec 8. Expert Rev Anticancer Ther. 2023. PMID: 38030394 Review.

10

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?

Jang A, Adler DM, Rauterkus GP, Bilen MA, Barata PC. Jang A, et al. Cancers (Basel). 2021 Oct 10;13(20):5065. doi: 10.3390/cancers13205065. Cancers (Basel). 2021. PMID: 34680214 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

861 results

Search Page

Filters